UnitedHealth Group shares rose by 2.75% on the most recent trading day, significantly outperforming the broader market benchmark. This gain came on higher-than-average trading volume, indicating strong investor interest in the company’s diversified business model. Over the past month, the stock has appreciated by more than 5%, while the S&P 500 index moved up roughly 1.8% over the same period. Analysts attribute this relative strength to steady growth in both the Optum health services segment and UnitedHealthcare’s core insurance operations.

In a prepared testimony released Wednesday, CEO Stephen Hemsley confirmed that UnitedHealth Group will issue rebates to its Affordable Care Act plan members in 2026. This move follows regulatory guidance on medical loss ratios, which requires insurers to return surplus premiums when medical spending falls below threshold levels. While the company has not quantified the total rebate pool, internal projections suggest rebates could benefit more than 2 million enrollees nationwide. Investors will be watching how this outflow affects UnitedHealth’s full-year underwriting margin and overall earnings outlook.